DisperSol (Aquired) Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • DisperSol (Aquired)'s estimated annual revenue is currently $11.7M per year.(i)
  • DisperSol (Aquired)'s estimated revenue per employee is $201,000

Employee Data

  • DisperSol (Aquired) has 58 Employees.(i)
  • DisperSol (Aquired) grew their employee count by 14% last year.

DisperSol (Aquired)'s People

NameTitleEmail/Phone
1
Analytical Chemist III - Analytical Team LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is DisperSol (Aquired)?

DisperSol Technologies provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules. DisperSol possesses a unique portfolio of technologies for the production of solubility enhanced systems that includes DisperSol's proprietary KinetiSolâ„¢ technology. As a non-solvent, fusion-based process that minimizes thermal stress with highly efficient mixing, KinetiSolâ„¢ is uniquely positioned to generate amorphous solid dispersion systems with the most challenging APIs and with the broadest spectrum of pharmaceutical polymers. DisperSol has established a rapid KinetiSolâ„¢ feasibility program whereby the applicability of the process to any NCE can be determined rapidly and with relatively little API. Following a successful KinetiSolâ„¢ feasibility program, DisperSol is positioned to provide formulations development and manufacturing services to support clinical studies at all phases.

keywords:N/A

N/A

Total Funding

58

Number of Employees

$11.7M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.1M580%N/A
#2
$5.3M59-5%N/A
#3
N/A6331%N/A
#4
$75M63-5%N/A
#5
$15.8M65-21%N/A